SPERO THERAPEUTICS INC (SPRO)
US84833T1034 - Common Stock
| TTM (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | 3.51M | 22.81M | -46.42M | -89.76M | -78.28M | |||
| Depreciation Amortization | 39.00K | 367.00K | 870.00K | 650.00K | 760.00K | |||
| Change In Working Capital | -30.40M | -70.38M | 22.09M | 12.86M | -13.46M | |||
| Taxes Paid | N/A | 2.21M | N/A | N/A | N/A | |||
| Other non cash items | 9.31M | 14.21M | 15.73M | 11.90M | 5.11M | |||
| OPERATING CASH FLOW | -17.54M | -32.99M | -7.73M | -64.35M | -85.87M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | N/A | N/A | N/A | N/A | -160.00K | |||
| Other Investing Activity | N/A | 0.00 | 33.81M | 7.67M | 10.63M | |||
| INVESTING CASH FLOW | N/A | 0.00 | 33.81M | 7.67M | 10.47M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | 0.00 | -54.49M | N/A | N/A | |||
| Stock Issued/Repurchased | N/A | 221.00K | 24.93M | 36.82M | 131.83M | |||
| Other Financing Activity | N/A | N/A | 0.00 | 47.23M | -950.00K | |||
| FINANCING CASH FLOW | N/A | 221.00K | -29.55M | 84.05M | 130.88M | |||
| CHANGE IN CASH | -17.54M | -32.77M | -3.47M | 27.37M | 55.48M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -17.54M | -32.99M | -7.73M | -64.35M | -85.87M | |||
| Capital Expenditure | N/A | N/A | N/A | N/A | -160.00K | |||
| FREE CASH FLOW | -17.54M | -32.99M | -7.73M | -64.35M | -86.03M | |||
All data in USD